Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab
Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the objective response rate of patients with
previously untreated metastatic colorectal cancer treated with the combination of cetuximab,
capecitabine, and oxaliplatin with out without bevacizumab.